Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Cardiff Oncology (CRDF) stocks in Canada
Learn how to easily invest in Cardiff Oncology stocks.
Cardiff Oncology is a biotechnology business based in the US. Cardiff Oncology stocks (CRDF.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $7.66 – a decrease of 15.95% over the previous week. Cardiff Oncology employs 11 staff and has a trailing 12-month revenue of around $344,993.
How to buy shares in Cardiff Oncology
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CRDF – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Cardiff Oncology?
- Has coronavirus impacted Cardiff Oncology shares?
- Cardiff Oncology shares summary
- Compare share dealing platforms
- Is Cardiff Oncology stock a buy or sell?
- Cardiff Oncology performance over time
- Cardiff Oncology's financials
- How volatile are Cardiff Oncology shares?
- Does Cardiff Oncology pay a dividend?
- Have Cardiff Oncology shares ever split?
- Other common questions
Cardiff Oncology stock price (NASDAQ:CRDF)Use our graph to track the performance of CRDF stocks over time.
Cardiff Oncology shares at a glance
|Latest market close||$3.11|
|52-week range||$3.31 - $14.98|
|50-day moving average||$5.79|
|200-day moving average||$6.77|
|Wall St. target price||$23.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.67|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Cardiff Oncology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Cardiff Oncology price performance over time
|1 week (2022-01-21)||-15.95%|
|1 month (2021-12-29)||-47.55%|
|3 months (2021-10-29)||-47.02%|
|6 months (2021-07-29)||-41.65%|
|1 year (2021-01-29)||-73.64%|
|2 years (2020-01-29)||88.48%|
|3 years (2019-01-29)||337.72%|
|5 years (2017-01-27)||55.50%|
Cardiff Oncology financials
|Gross profit TTM||$-10,869,403|
|Return on assets TTM||-17.65%|
|Return on equity TTM||-30.46%|
|Market capitalisation||$151.9 million|
TTM: trailing 12 months
Cardiff Oncology share dividends
We're not expecting Cardiff Oncology to pay a dividend over the next 12 months.
Have Cardiff Oncology's shares ever split?
Cardiff Oncology's shares were split on a 1:6 basis on 19 February 2019. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cardiff Oncology shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Cardiff Oncology shares which in turn could have impacted Cardiff Oncology's share price.
Cardiff Oncology share price volatility
Over the last 12 months, Cardiff Oncology's shares have ranged in value from as little as $3.31 up to $14.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cardiff Oncology's is 1.6564. This would suggest that Cardiff Oncology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cardiff Oncology overview
Cardiff Oncology, Inc. , a clinical-stage biotechnology company, develops drugs for the treatment of cancer. Its lead drug candidate is onvansertib, a Polo-like Kinase 1 selective adenosine triphosphate competitive inhibitor that is in Phase Ib/II clinical trial in acute myeloid leukemia (AML); has completed a Phase I clinical trial in advanced solid tumors; and Phase Ib/II clinical trial for metastatic colorectal cancer in combination with FOLFIRI and Avastin. The company's onvansertib is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. In addition, it develops therapeutics, such as belinostat (Beleodaq); quizartinib (AC220), a development stage FLT3 inhibitor; and bortezomib (Velcade) for the treatment of leukemias, lymphomas, and solid tumor cancers. The company primarily serves pharmaceutical companies. Cardiff Oncology, Inc.
Stocks similar to Cardiff Oncology
Cardiff Oncology in the news
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
48 Biggest Movers From Yesterday
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.